Effectiveness of the Non-Stimulant Medication Lobeline in Improving Symptoms of Attention Deficit Hyperactivity Disorder in Adults - Related Studies

Effectiveness of the Non-Stimulant Medication Lobeline in Improving Symptoms of Attention Deficit Hyperactivity Disorder in Adults

This study is currently recruiting participants.

Study NCT00664703. Last updated on July 1, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Attention Deficit Disorder with Hyperactivity
		Disease
		Hyperkinesis

2	More general conditions related to this trial
		Attention Deficit and Disruptive Behavior Disorders
		Dyskinesias
		Mental Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

3	Interventions listed in this trial
		Lobeline Placebo
		Lobeline Mid Dose
		Lobeline Low Dose
		Lobeline High Dose
		Methylphenidate Low Dose
		Methylphenidate High Dose
		Methylphenidate Placebo

4	Additional drug interventions recognized in this trial
		Lobeline
		Methylphenidate

5	More general drug interventions related to this trial
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Stimulants
		Cholinergic Agents
		Cholinergic Agonists
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Ganglionic Stimulants
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Nicotinic Agonists
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Respiratory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)